Sign in to view content

Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice

Andrew A. Moshfeghi, MD, MBA, FASRS

Video
Published 2018

Related

Applying the DRCR.net Anti-VEGF Treatment Algorithm for Proliferative Diabetic Retinopathy: Neovascular Outcomes Over 2 Years
Christina Joy Flaxel, MD
Annual Meeting Talks
2018
Safety and Activity of a Single, Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa (RP)
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2018
Founders' Award, Playing Your Part in Drug Development, Wiley Chambers, MD
Wiley Chambers, MD
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more